Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine

Clozapine, a dibenzodiazepine developed in 1961, is a multireceptorial atypical antipsychotic approved for the treatment of resistant schizophrenia. Since its introduction, it has remained the drug of choice in treatment-resistant schizophrenia, despite a wide range of adverse effects, as it is a ve...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Ther Adv Drug Saf
Κύριοι συγγραφείς: De Berardis, Domenico, Rapini, Gabriella, Olivieri, Luigi, Di Nicola, Domenico, Tomasetti, Carmine, Valchera, Alessandro, Fornaro, Michele, Di Fabio, Fabio, Perna, Giampaolo, Di Nicola, Marco, Serafini, Gianluca, Carano, Alessandro, Pompili, Maurizio, Vellante, Federica, Orsolini, Laura, Martinotti, Giovanni, Di Giannantonio, Massimo
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: SAGE Publications 2018
Θέματα:
Reviews
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5956953/
https://ncbi.nlm.nih.gov/pubmed/29796248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042098618756261
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια